The Role of Translational Medicine and Predictive Biomarkers in the Development of Novel, Innovative Treatments for the Management of Chronic Heart Failure: A Pharmaceutical Industry Perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Role of Translational Medicine and Predictive Biomarkers in the Development of Novel, Innovative Treatments for the Management of Chronic Heart Failure: A Pharmaceutical Industry Perspective

Published:2010-09-15 Issue: Volume: Page:477-514
ISSN:
Container-title:Burger's Medicinal Chemistry and Drug Discovery
language:
Short-container-title:

Author:

Douglas Stephen A.,Feuerstein Giora Z.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/0471266949.bmc187

Reference124 articles.

1. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines;Hunt SA;Circulation,2005

2. Lifetime Risk for Developing Congestive Heart Failure

3. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

4. Deaths: preliminary data for 2004;Minino AM;Natl Vital Stat Rep,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP